Oxysterol metabolism balance as a candidate biomarker in autism spectrum disorder

dc.authorid0000-0002-5486-7377
dc.authorid0000-0002-2381-5742
dc.authorid0000-0003-3078-999X
dc.authorid0000-0002-6564-3133
dc.authorid0000-0002-3014-748X
dc.authorid0000-0003-4206-3766
dc.authorid0000-0002-7051-5662
dc.authorid0000-0003-3189-2112
dc.contributor.authorMenteşe Babayiğit, Tuğba
dc.contributor.authorÇıkılı Uytun, Merve
dc.contributor.authorDoğan, Özlem
dc.contributor.authorAkay, Güvem Gümüş
dc.contributor.authorSerdar, Muhittin A.
dc.contributor.authorEfendi, Gökçe Yağmur
dc.contributor.authorYürümez, Esra
dc.contributor.authorÖztop, Didem Behice
dc.date.accessioned2024-08-02T10:59:15Z
dc.date.available2024-08-02T10:59:15Z
dc.date.issued2024
dc.departmentTıp Fakültesi
dc.description.abstractThe aim of this study was to investigate the role of cholesterol metabolism disorders in the etiopathogenesis of Autism Spectrum Disorder (ASD) through the analysis of central and peripheral oxysterol levels (24-hydroxycholesterol,25-hydroxycholesterol,27-hydroxycholesterol). These compounds, found in the cholesterol excretion pathways, are considered potential biomarkers for diagnosing and monitoring various neuropsychiatric disorders. Materials and Methods: This study included 42 children diagnosed with ASD, aged between 1 and 6 years, who had no additional psychiatric or medical illnesses other than cognitive delay/intellectual disability and were not on medication, along with 38 age -matched typically developing children. After comprehensive mental health assessments, the symptom severity in children with ASD was evaluated using the Childhood Autism Rating Scale, Autism Behavior Checklist, and Repetitive Behavior Scale -Revised Form. After the clinical evaluation, peripheral blood samples were obtained from all children. Oxysterol levels were assessed using liquid chromatography coupled with tandem mass spectrometry. Results: In the ASD group, levels of 24-hydroxycholesterol and 25-hydroxycholesterol were significantly higher compared to the control group, while 27-R-hydroxycholesterol levels were lower. The ratio of 24-hydroxycholesterol (mu g/L) to 27-hydroxycholesterol (mu g/L) was notably higher in the autism group. The receiver operating characteristic (ROC) analysis indicated that this ratio was statistically significant and could discriminate between ASD and non-ASD diagnoses with "acceptable discrimination potential." Conclusion: Our findings suggest that alterations in oxysterol levels, commonly associated with neurodegenerative processes, can also be observed in ASD and may serve as a potential candidate biomarker for the disorder.
dc.identifier.doi10.14744/cpr.2024.28664
dc.identifier.endpage297en_US
dc.identifier.issn2980-2156
dc.identifier.issue3en_US
dc.identifier.startpage290en_US
dc.identifier.urihttps:/dx.doi.org/10.14744/cpr.2024.28664
dc.identifier.urihttps://hdl.handle.net/20.500.12451/12310
dc.identifier.volume46en_US
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherKayseri Faculty of Medicine
dc.relation.ispartofJournal of Clinical Practice and Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAutism Spectrum Disorder
dc.subjectBiomarker
dc.subjectOxysterol
dc.subject24-hydroxycholesterol
dc.subject27-hydroxycholesterol
dc.titleOxysterol metabolism balance as a candidate biomarker in autism spectrum disorder
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
mentese babayigit-tugba-2024.pdf
Boyut:
121.16 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: